nodes	percent_of_prediction	percent_of_DWPC	metapath
Rufinamide—Tremor—Cisplatin—testicular cancer	0.00264	0.00264	CcSEcCtD
Rufinamide—Nervous system disorder—Ifosfamide—testicular cancer	0.00262	0.00262	CcSEcCtD
Rufinamide—Thrombocytopenia—Ifosfamide—testicular cancer	0.00261	0.00261	CcSEcCtD
Rufinamide—Lymphadenopathy—Doxorubicin—testicular cancer	0.00261	0.00261	CcSEcCtD
Rufinamide—Anaemia—Cisplatin—testicular cancer	0.0026	0.0026	CcSEcCtD
Rufinamide—Skin disorder—Ifosfamide—testicular cancer	0.00259	0.00259	CcSEcCtD
Rufinamide—Vomiting—Chlorambucil—testicular cancer	0.00256	0.00256	CcSEcCtD
Rufinamide—Increased appetite—Epirubicin—testicular cancer	0.00256	0.00256	CcSEcCtD
Rufinamide—Anorexia—Ifosfamide—testicular cancer	0.00254	0.00254	CcSEcCtD
Rufinamide—Decreased appetite—Dactinomycin—testicular cancer	0.00253	0.00253	CcSEcCtD
Rufinamide—Diarrhoea—Vinblastine—testicular cancer	0.00253	0.00253	CcSEcCtD
Rufinamide—Leukopenia—Cisplatin—testicular cancer	0.00252	0.00252	CcSEcCtD
Rufinamide—Fatigue—Dactinomycin—testicular cancer	0.00251	0.00251	CcSEcCtD
Rufinamide—Back pain—Etoposide—testicular cancer	0.0025	0.0025	CcSEcCtD
Rufinamide—Dizziness—Vinblastine—testicular cancer	0.00244	0.00244	CcSEcCtD
Rufinamide—Convulsion—Cisplatin—testicular cancer	0.00244	0.00244	CcSEcCtD
Rufinamide—Ataxia—Methotrexate—testicular cancer	0.00241	0.00241	CcSEcCtD
Rufinamide—Diplopia—Epirubicin—testicular cancer	0.0024	0.0024	CcSEcCtD
Rufinamide—Nausea—Chlorambucil—testicular cancer	0.0024	0.0024	CcSEcCtD
Rufinamide—Anxiety—Cisplatin—testicular cancer	0.00239	0.00239	CcSEcCtD
Rufinamide—Anaemia—Etoposide—testicular cancer	0.00239	0.00239	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.00238	0.00238	CcSEcCtD
Rufinamide—Somnolence—Ifosfamide—testicular cancer	0.00237	0.00237	CcSEcCtD
Rufinamide—Increased appetite—Doxorubicin—testicular cancer	0.00237	0.00237	CcSEcCtD
Rufinamide—Vomiting—Vinblastine—testicular cancer	0.00235	0.00235	CcSEcCtD
Rufinamide—Breast disorder—Methotrexate—testicular cancer	0.00232	0.00232	CcSEcCtD
Rufinamide—Vertigo—Etoposide—testicular cancer	0.00232	0.00232	CcSEcCtD
Rufinamide—Decreased appetite—Ifosfamide—testicular cancer	0.00232	0.00232	CcSEcCtD
Rufinamide—Headache—Vinblastine—testicular cancer	0.00232	0.00232	CcSEcCtD
Rufinamide—Leukopenia—Etoposide—testicular cancer	0.00231	0.00231	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.0023	0.0023	CcSEcCtD
Rufinamide—Fatigue—Ifosfamide—testicular cancer	0.0023	0.0023	CcSEcCtD
Rufinamide—Hypersensitivity—Bleomycin—testicular cancer	0.0023	0.0023	CcSEcCtD
Rufinamide—Infection—Cisplatin—testicular cancer	0.00229	0.00229	CcSEcCtD
Rufinamide—Constipation—Ifosfamide—testicular cancer	0.00228	0.00228	CcSEcCtD
Rufinamide—Ataxia—Epirubicin—testicular cancer	0.00226	0.00226	CcSEcCtD
Rufinamide—Nervous system disorder—Cisplatin—testicular cancer	0.00226	0.00226	CcSEcCtD
Rufinamide—Thrombocytopenia—Cisplatin—testicular cancer	0.00225	0.00225	CcSEcCtD
Rufinamide—Asthenia—Bleomycin—testicular cancer	0.00224	0.00224	CcSEcCtD
Rufinamide—Convulsion—Etoposide—testicular cancer	0.00224	0.00224	CcSEcCtD
Rufinamide—Skin disorder—Cisplatin—testicular cancer	0.00223	0.00223	CcSEcCtD
Rufinamide—Diplopia—Doxorubicin—testicular cancer	0.00222	0.00222	CcSEcCtD
Rufinamide—Pruritus—Bleomycin—testicular cancer	0.00221	0.00221	CcSEcCtD
Rufinamide—Nausea—Vinblastine—testicular cancer	0.0022	0.0022	CcSEcCtD
Rufinamide—Abdominal pain upper—Epirubicin—testicular cancer	0.0022	0.0022	CcSEcCtD
Rufinamide—Anorexia—Cisplatin—testicular cancer	0.00219	0.00219	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.00218	0.00218	CcSEcCtD
Rufinamide—Breast disorder—Epirubicin—testicular cancer	0.00217	0.00217	CcSEcCtD
Rufinamide—Nasopharyngitis—Epirubicin—testicular cancer	0.00215	0.00215	CcSEcCtD
Rufinamide—Hypersensitivity—Dactinomycin—testicular cancer	0.00215	0.00215	CcSEcCtD
Rufinamide—Infection—Etoposide—testicular cancer	0.00209	0.00209	CcSEcCtD
Rufinamide—Ataxia—Doxorubicin—testicular cancer	0.00209	0.00209	CcSEcCtD
Rufinamide—Asthenia—Dactinomycin—testicular cancer	0.00209	0.00209	CcSEcCtD
Rufinamide—Influenza—Epirubicin—testicular cancer	0.00208	0.00208	CcSEcCtD
Rufinamide—Dysuria—Methotrexate—testicular cancer	0.00208	0.00208	CcSEcCtD
Rufinamide—Neutropenia—Methotrexate—testicular cancer	0.00208	0.00208	CcSEcCtD
Rufinamide—Thrombocytopenia—Etoposide—testicular cancer	0.00206	0.00206	CcSEcCtD
Rufinamide—Skin disorder—Etoposide—testicular cancer	0.00205	0.00205	CcSEcCtD
Rufinamide—Abdominal pain upper—Doxorubicin—testicular cancer	0.00203	0.00203	CcSEcCtD
Rufinamide—Breast disorder—Doxorubicin—testicular cancer	0.00201	0.00201	CcSEcCtD
Rufinamide—Anorexia—Etoposide—testicular cancer	0.00201	0.00201	CcSEcCtD
Rufinamide—Decreased appetite—Cisplatin—testicular cancer	0.002	0.002	CcSEcCtD
Rufinamide—Bronchitis—Epirubicin—testicular cancer	0.002	0.002	CcSEcCtD
Rufinamide—Diarrhoea—Dactinomycin—testicular cancer	0.00199	0.00199	CcSEcCtD
Rufinamide—Pneumonia—Methotrexate—testicular cancer	0.00199	0.00199	CcSEcCtD
Rufinamide—Nasopharyngitis—Doxorubicin—testicular cancer	0.00199	0.00199	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00199	0.00199	CcSEcCtD
Rufinamide—Vomiting—Bleomycin—testicular cancer	0.00198	0.00198	CcSEcCtD
Rufinamide—Infestation NOS—Methotrexate—testicular cancer	0.00198	0.00198	CcSEcCtD
Rufinamide—Infestation—Methotrexate—testicular cancer	0.00198	0.00198	CcSEcCtD
Rufinamide—Rash—Bleomycin—testicular cancer	0.00197	0.00197	CcSEcCtD
Rufinamide—Dermatitis—Bleomycin—testicular cancer	0.00197	0.00197	CcSEcCtD
Rufinamide—Hypersensitivity—Ifosfamide—testicular cancer	0.00197	0.00197	CcSEcCtD
Rufinamide—Dysuria—Epirubicin—testicular cancer	0.00194	0.00194	CcSEcCtD
Rufinamide—Neutropenia—Epirubicin—testicular cancer	0.00194	0.00194	CcSEcCtD
Rufinamide—Influenza—Doxorubicin—testicular cancer	0.00192	0.00192	CcSEcCtD
Rufinamide—Pollakiuria—Epirubicin—testicular cancer	0.00192	0.00192	CcSEcCtD
Rufinamide—Asthenia—Ifosfamide—testicular cancer	0.00191	0.00191	CcSEcCtD
Rufinamide—Pruritus—Ifosfamide—testicular cancer	0.00189	0.00189	CcSEcCtD
Rufinamide—Haematuria—Methotrexate—testicular cancer	0.00189	0.00189	CcSEcCtD
Rufinamide—Weight decreased—Epirubicin—testicular cancer	0.00188	0.00188	CcSEcCtD
Rufinamide—Somnolence—Etoposide—testicular cancer	0.00187	0.00187	CcSEcCtD
Rufinamide—Hepatobiliary disease—Methotrexate—testicular cancer	0.00187	0.00187	CcSEcCtD
Rufinamide—Epistaxis—Methotrexate—testicular cancer	0.00187	0.00187	CcSEcCtD
Rufinamide—Pneumonia—Epirubicin—testicular cancer	0.00186	0.00186	CcSEcCtD
Rufinamide—Nausea—Bleomycin—testicular cancer	0.00185	0.00185	CcSEcCtD
Rufinamide—Infestation NOS—Epirubicin—testicular cancer	0.00185	0.00185	CcSEcCtD
Rufinamide—Infestation—Epirubicin—testicular cancer	0.00185	0.00185	CcSEcCtD
Rufinamide—Vomiting—Dactinomycin—testicular cancer	0.00185	0.00185	CcSEcCtD
Rufinamide—Bronchitis—Doxorubicin—testicular cancer	0.00185	0.00185	CcSEcCtD
Rufinamide—Rash—Dactinomycin—testicular cancer	0.00184	0.00184	CcSEcCtD
Rufinamide—Decreased appetite—Etoposide—testicular cancer	0.00183	0.00183	CcSEcCtD
Rufinamide—Diarrhoea—Ifosfamide—testicular cancer	0.00183	0.00183	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Etoposide—testicular cancer	0.00182	0.00182	CcSEcCtD
Rufinamide—Fatigue—Etoposide—testicular cancer	0.00182	0.00182	CcSEcCtD
Rufinamide—Constipation—Etoposide—testicular cancer	0.0018	0.0018	CcSEcCtD
Rufinamide—Dysuria—Doxorubicin—testicular cancer	0.0018	0.0018	CcSEcCtD
Rufinamide—Neutropenia—Doxorubicin—testicular cancer	0.0018	0.0018	CcSEcCtD
Rufinamide—Pollakiuria—Doxorubicin—testicular cancer	0.00178	0.00178	CcSEcCtD
Rufinamide—Haematuria—Epirubicin—testicular cancer	0.00177	0.00177	CcSEcCtD
Rufinamide—Dizziness—Ifosfamide—testicular cancer	0.00176	0.00176	CcSEcCtD
Rufinamide—Urinary tract disorder—Methotrexate—testicular cancer	0.00175	0.00175	CcSEcCtD
Rufinamide—Hepatobiliary disease—Epirubicin—testicular cancer	0.00175	0.00175	CcSEcCtD
Rufinamide—Epistaxis—Epirubicin—testicular cancer	0.00175	0.00175	CcSEcCtD
Rufinamide—Urethral disorder—Methotrexate—testicular cancer	0.00174	0.00174	CcSEcCtD
Rufinamide—Weight decreased—Doxorubicin—testicular cancer	0.00174	0.00174	CcSEcCtD
Rufinamide—Sinusitis—Epirubicin—testicular cancer	0.00174	0.00174	CcSEcCtD
Rufinamide—Nausea—Dactinomycin—testicular cancer	0.00173	0.00173	CcSEcCtD
Rufinamide—Pneumonia—Doxorubicin—testicular cancer	0.00172	0.00172	CcSEcCtD
Rufinamide—Infestation NOS—Doxorubicin—testicular cancer	0.00171	0.00171	CcSEcCtD
Rufinamide—Infestation—Doxorubicin—testicular cancer	0.00171	0.00171	CcSEcCtD
Rufinamide—Vomiting—Ifosfamide—testicular cancer	0.0017	0.0017	CcSEcCtD
Rufinamide—Hypersensitivity—Cisplatin—testicular cancer	0.00169	0.00169	CcSEcCtD
Rufinamide—Rash—Ifosfamide—testicular cancer	0.00168	0.00168	CcSEcCtD
Rufinamide—Dermatitis—Ifosfamide—testicular cancer	0.00168	0.00168	CcSEcCtD
Rufinamide—Rhinitis—Epirubicin—testicular cancer	0.00167	0.00167	CcSEcCtD
Rufinamide—Eye disorder—Methotrexate—testicular cancer	0.00166	0.00166	CcSEcCtD
Rufinamide—Asthenia—Cisplatin—testicular cancer	0.00165	0.00165	CcSEcCtD
Rufinamide—Cardiac disorder—Methotrexate—testicular cancer	0.00165	0.00165	CcSEcCtD
Rufinamide—Urinary tract disorder—Epirubicin—testicular cancer	0.00164	0.00164	CcSEcCtD
Rufinamide—Haematuria—Doxorubicin—testicular cancer	0.00163	0.00163	CcSEcCtD
Rufinamide—Urethral disorder—Epirubicin—testicular cancer	0.00163	0.00163	CcSEcCtD
Rufinamide—Hepatobiliary disease—Doxorubicin—testicular cancer	0.00162	0.00162	CcSEcCtD
Rufinamide—Epistaxis—Doxorubicin—testicular cancer	0.00162	0.00162	CcSEcCtD
Rufinamide—Sinusitis—Doxorubicin—testicular cancer	0.00161	0.00161	CcSEcCtD
Rufinamide—Immune system disorder—Methotrexate—testicular cancer	0.0016	0.0016	CcSEcCtD
Rufinamide—Mediastinal disorder—Methotrexate—testicular cancer	0.0016	0.0016	CcSEcCtD
Rufinamide—Nausea—Ifosfamide—testicular cancer	0.00158	0.00158	CcSEcCtD
Rufinamide—Diarrhoea—Cisplatin—testicular cancer	0.00157	0.00157	CcSEcCtD
Rufinamide—Mental disorder—Methotrexate—testicular cancer	0.00156	0.00156	CcSEcCtD
Rufinamide—Eye disorder—Epirubicin—testicular cancer	0.00155	0.00155	CcSEcCtD
Rufinamide—Hypersensitivity—Etoposide—testicular cancer	0.00155	0.00155	CcSEcCtD
Rufinamide—Malnutrition—Methotrexate—testicular cancer	0.00155	0.00155	CcSEcCtD
Rufinamide—Cardiac disorder—Epirubicin—testicular cancer	0.00154	0.00154	CcSEcCtD
Rufinamide—Rhinitis—Doxorubicin—testicular cancer	0.00154	0.00154	CcSEcCtD
Rufinamide—Urinary tract disorder—Doxorubicin—testicular cancer	0.00152	0.00152	CcSEcCtD
Rufinamide—Asthenia—Etoposide—testicular cancer	0.00151	0.00151	CcSEcCtD
Rufinamide—Urethral disorder—Doxorubicin—testicular cancer	0.00151	0.00151	CcSEcCtD
Rufinamide—Immune system disorder—Epirubicin—testicular cancer	0.0015	0.0015	CcSEcCtD
Rufinamide—Mediastinal disorder—Epirubicin—testicular cancer	0.0015	0.0015	CcSEcCtD
Rufinamide—Back pain—Methotrexate—testicular cancer	0.0015	0.0015	CcSEcCtD
Rufinamide—Pruritus—Etoposide—testicular cancer	0.00149	0.00149	CcSEcCtD
Rufinamide—Vomiting—Cisplatin—testicular cancer	0.00146	0.00146	CcSEcCtD
Rufinamide—Vision blurred—Methotrexate—testicular cancer	0.00146	0.00146	CcSEcCtD
Rufinamide—Mental disorder—Epirubicin—testicular cancer	0.00146	0.00146	CcSEcCtD
Rufinamide—Rash—Cisplatin—testicular cancer	0.00145	0.00145	CcSEcCtD
Rufinamide—Dermatitis—Cisplatin—testicular cancer	0.00145	0.00145	CcSEcCtD
Rufinamide—Malnutrition—Epirubicin—testicular cancer	0.00145	0.00145	CcSEcCtD
Rufinamide—Diarrhoea—Etoposide—testicular cancer	0.00144	0.00144	CcSEcCtD
Rufinamide—Eye disorder—Doxorubicin—testicular cancer	0.00144	0.00144	CcSEcCtD
Rufinamide—Anaemia—Methotrexate—testicular cancer	0.00143	0.00143	CcSEcCtD
Rufinamide—Cardiac disorder—Doxorubicin—testicular cancer	0.00143	0.00143	CcSEcCtD
Rufinamide—Back pain—Epirubicin—testicular cancer	0.0014	0.0014	CcSEcCtD
Rufinamide—Dizziness—Etoposide—testicular cancer	0.00139	0.00139	CcSEcCtD
Rufinamide—Immune system disorder—Doxorubicin—testicular cancer	0.00139	0.00139	CcSEcCtD
Rufinamide—Vertigo—Methotrexate—testicular cancer	0.00139	0.00139	CcSEcCtD
Rufinamide—Mediastinal disorder—Doxorubicin—testicular cancer	0.00139	0.00139	CcSEcCtD
Rufinamide—Leukopenia—Methotrexate—testicular cancer	0.00138	0.00138	CcSEcCtD
Rufinamide—Nausea—Cisplatin—testicular cancer	0.00137	0.00137	CcSEcCtD
Rufinamide—Vision blurred—Epirubicin—testicular cancer	0.00136	0.00136	CcSEcCtD
Rufinamide—Mental disorder—Doxorubicin—testicular cancer	0.00135	0.00135	CcSEcCtD
Rufinamide—Convulsion—Methotrexate—testicular cancer	0.00134	0.00134	CcSEcCtD
Rufinamide—Vomiting—Etoposide—testicular cancer	0.00134	0.00134	CcSEcCtD
Rufinamide—Malnutrition—Doxorubicin—testicular cancer	0.00134	0.00134	CcSEcCtD
Rufinamide—Anaemia—Epirubicin—testicular cancer	0.00134	0.00134	CcSEcCtD
Rufinamide—Agitation—Epirubicin—testicular cancer	0.00133	0.00133	CcSEcCtD
Rufinamide—Rash—Etoposide—testicular cancer	0.00133	0.00133	CcSEcCtD
Rufinamide—Dermatitis—Etoposide—testicular cancer	0.00133	0.00133	CcSEcCtD
Rufinamide—Headache—Etoposide—testicular cancer	0.00132	0.00132	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.00131	0.00131	CcSEcCtD
Rufinamide—Vertigo—Epirubicin—testicular cancer	0.0013	0.0013	CcSEcCtD
Rufinamide—Leukopenia—Epirubicin—testicular cancer	0.0013	0.0013	CcSEcCtD
Rufinamide—Back pain—Doxorubicin—testicular cancer	0.0013	0.0013	CcSEcCtD
Rufinamide—Vision blurred—Doxorubicin—testicular cancer	0.00126	0.00126	CcSEcCtD
Rufinamide—Convulsion—Epirubicin—testicular cancer	0.00125	0.00125	CcSEcCtD
Rufinamide—Infection—Methotrexate—testicular cancer	0.00125	0.00125	CcSEcCtD
Rufinamide—Nausea—Etoposide—testicular cancer	0.00125	0.00125	CcSEcCtD
Rufinamide—Nervous system disorder—Methotrexate—testicular cancer	0.00124	0.00124	CcSEcCtD
Rufinamide—Anaemia—Doxorubicin—testicular cancer	0.00124	0.00124	CcSEcCtD
Rufinamide—Thrombocytopenia—Methotrexate—testicular cancer	0.00124	0.00124	CcSEcCtD
Rufinamide—Agitation—Doxorubicin—testicular cancer	0.00123	0.00123	CcSEcCtD
Rufinamide—Anxiety—Epirubicin—testicular cancer	0.00123	0.00123	CcSEcCtD
Rufinamide—Skin disorder—Methotrexate—testicular cancer	0.00123	0.00123	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.00122	0.00122	CcSEcCtD
Rufinamide—Vertigo—Doxorubicin—testicular cancer	0.0012	0.0012	CcSEcCtD
Rufinamide—Anorexia—Methotrexate—testicular cancer	0.0012	0.0012	CcSEcCtD
Rufinamide—Leukopenia—Doxorubicin—testicular cancer	0.0012	0.0012	CcSEcCtD
Rufinamide—Infection—Epirubicin—testicular cancer	0.00117	0.00117	CcSEcCtD
Rufinamide—Convulsion—Doxorubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Rufinamide—Nervous system disorder—Epirubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Rufinamide—Thrombocytopenia—Epirubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Rufinamide—Skin disorder—Epirubicin—testicular cancer	0.00115	0.00115	CcSEcCtD
Rufinamide—Insomnia—Methotrexate—testicular cancer	0.00114	0.00114	CcSEcCtD
Rufinamide—Anxiety—Doxorubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.00113	0.00113	CcSEcCtD
Rufinamide—Anorexia—Epirubicin—testicular cancer	0.00113	0.00113	CcSEcCtD
Rufinamide—Somnolence—Methotrexate—testicular cancer	0.00112	0.00112	CcSEcCtD
Rufinamide—Dyspepsia—Methotrexate—testicular cancer	0.00111	0.00111	CcSEcCtD
Rufinamide—Decreased appetite—Methotrexate—testicular cancer	0.0011	0.0011	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Methotrexate—testicular cancer	0.00109	0.00109	CcSEcCtD
Rufinamide—Fatigue—Methotrexate—testicular cancer	0.00109	0.00109	CcSEcCtD
Rufinamide—Infection—Doxorubicin—testicular cancer	0.00109	0.00109	CcSEcCtD
Rufinamide—Nervous system disorder—Doxorubicin—testicular cancer	0.00107	0.00107	CcSEcCtD
Rufinamide—Thrombocytopenia—Doxorubicin—testicular cancer	0.00107	0.00107	CcSEcCtD
Rufinamide—Insomnia—Epirubicin—testicular cancer	0.00107	0.00107	CcSEcCtD
Rufinamide—Skin disorder—Doxorubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Rufinamide—Somnolence—Epirubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Rufinamide—Anorexia—Doxorubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Rufinamide—Dyspepsia—Epirubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Rufinamide—Decreased appetite—Epirubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Epirubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Rufinamide—Fatigue—Epirubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Rufinamide—Constipation—Epirubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Rufinamide—Insomnia—Doxorubicin—testicular cancer	0.000989	0.000989	CcSEcCtD
Rufinamide—Somnolence—Doxorubicin—testicular cancer	0.000972	0.000972	CcSEcCtD
Rufinamide—Dyspepsia—Doxorubicin—testicular cancer	0.000962	0.000962	CcSEcCtD
Rufinamide—Decreased appetite—Doxorubicin—testicular cancer	0.00095	0.00095	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000944	0.000944	CcSEcCtD
Rufinamide—Fatigue—Doxorubicin—testicular cancer	0.000942	0.000942	CcSEcCtD
Rufinamide—Constipation—Doxorubicin—testicular cancer	0.000935	0.000935	CcSEcCtD
Rufinamide—Hypersensitivity—Methotrexate—testicular cancer	0.00093	0.00093	CcSEcCtD
Rufinamide—Asthenia—Methotrexate—testicular cancer	0.000906	0.000906	CcSEcCtD
Rufinamide—Pruritus—Methotrexate—testicular cancer	0.000893	0.000893	CcSEcCtD
Rufinamide—Hypersensitivity—Epirubicin—testicular cancer	0.00087	0.00087	CcSEcCtD
Rufinamide—Diarrhoea—Methotrexate—testicular cancer	0.000864	0.000864	CcSEcCtD
Rufinamide—Asthenia—Epirubicin—testicular cancer	0.000848	0.000848	CcSEcCtD
Rufinamide—Pruritus—Epirubicin—testicular cancer	0.000836	0.000836	CcSEcCtD
Rufinamide—Dizziness—Methotrexate—testicular cancer	0.000835	0.000835	CcSEcCtD
Rufinamide—Diarrhoea—Epirubicin—testicular cancer	0.000808	0.000808	CcSEcCtD
Rufinamide—Hypersensitivity—Doxorubicin—testicular cancer	0.000805	0.000805	CcSEcCtD
Rufinamide—Vomiting—Methotrexate—testicular cancer	0.000803	0.000803	CcSEcCtD
Rufinamide—Rash—Methotrexate—testicular cancer	0.000796	0.000796	CcSEcCtD
Rufinamide—Dermatitis—Methotrexate—testicular cancer	0.000795	0.000795	CcSEcCtD
Rufinamide—Headache—Methotrexate—testicular cancer	0.000791	0.000791	CcSEcCtD
Rufinamide—Asthenia—Doxorubicin—testicular cancer	0.000784	0.000784	CcSEcCtD
Rufinamide—Dizziness—Epirubicin—testicular cancer	0.000781	0.000781	CcSEcCtD
Rufinamide—Pruritus—Doxorubicin—testicular cancer	0.000773	0.000773	CcSEcCtD
Rufinamide—Vomiting—Epirubicin—testicular cancer	0.000751	0.000751	CcSEcCtD
Rufinamide—Nausea—Methotrexate—testicular cancer	0.00075	0.00075	CcSEcCtD
Rufinamide—Diarrhoea—Doxorubicin—testicular cancer	0.000748	0.000748	CcSEcCtD
Rufinamide—Rash—Epirubicin—testicular cancer	0.000745	0.000745	CcSEcCtD
Rufinamide—Dermatitis—Epirubicin—testicular cancer	0.000744	0.000744	CcSEcCtD
Rufinamide—Headache—Epirubicin—testicular cancer	0.00074	0.00074	CcSEcCtD
Rufinamide—Dizziness—Doxorubicin—testicular cancer	0.000723	0.000723	CcSEcCtD
Rufinamide—Nausea—Epirubicin—testicular cancer	0.000702	0.000702	CcSEcCtD
Rufinamide—Vomiting—Doxorubicin—testicular cancer	0.000695	0.000695	CcSEcCtD
Rufinamide—Rash—Doxorubicin—testicular cancer	0.000689	0.000689	CcSEcCtD
Rufinamide—Dermatitis—Doxorubicin—testicular cancer	0.000689	0.000689	CcSEcCtD
Rufinamide—Headache—Doxorubicin—testicular cancer	0.000685	0.000685	CcSEcCtD
Rufinamide—Nausea—Doxorubicin—testicular cancer	0.000649	0.000649	CcSEcCtD
